IL143196A0 - Method of preparing stable suspensions of insoluble microparticles - Google Patents
Method of preparing stable suspensions of insoluble microparticlesInfo
- Publication number
- IL143196A0 IL143196A0 IL14319699A IL14319699A IL143196A0 IL 143196 A0 IL143196 A0 IL 143196A0 IL 14319699 A IL14319699 A IL 14319699A IL 14319699 A IL14319699 A IL 14319699A IL 143196 A0 IL143196 A0 IL 143196A0
- Authority
- IL
- Israel
- Prior art keywords
- preparing stable
- stable suspensions
- insoluble microparticles
- microparticles
- insoluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10920398P | 1998-11-20 | 1998-11-20 | |
| PCT/US1999/027435 WO2000030615A1 (en) | 1998-11-20 | 1999-11-19 | Method of preparing stable suspensions of insoluble microparticles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL143196A0 true IL143196A0 (en) | 2002-04-21 |
Family
ID=22326359
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14319699A IL143196A0 (en) | 1998-11-20 | 1999-11-19 | Method of preparing stable suspensions of insoluble microparticles |
| IL143196A IL143196A (en) | 1998-11-20 | 2001-05-17 | Stable suspensions of insoluble microparticles |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL143196A IL143196A (en) | 1998-11-20 | 2001-05-17 | Stable suspensions of insoluble microparticles |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1133280A1 (ko) |
| JP (1) | JP5296954B2 (ko) |
| KR (1) | KR20010075713A (ko) |
| CN (1) | CN1213733C (ko) |
| AU (1) | AU767737B2 (ko) |
| CA (1) | CA2349202C (ko) |
| IL (2) | IL143196A0 (ko) |
| WO (1) | WO2000030615A1 (ko) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001247244B2 (en) * | 2000-02-28 | 2005-06-02 | Genesegues, Inc. | Nanocapsule encapsulation system and method |
| MY120279A (en) | 2000-05-26 | 2005-09-30 | Pharmacia Corp | Use of a celecoxib composition for fast pain relief |
| US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
| US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
| FR2819720B1 (fr) | 2001-01-22 | 2004-03-12 | Fournier Lab Sa | Nouveaux comprimes de fenofibrate |
| GB0119480D0 (en) | 2001-08-09 | 2001-10-03 | Jagotec Ag | Novel compositions |
| US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| CA2461349C (en) | 2001-09-26 | 2011-11-29 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
| UY27939A1 (es) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
| US7828996B1 (en) | 2009-03-27 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Method for the manufacture of stable, nano-sized particles |
| EP2785734B1 (en) * | 2011-11-30 | 2017-11-01 | Agency For Science, Technology And Research | Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring |
| CN114367383B (zh) * | 2022-01-13 | 2024-01-09 | 苏州丰倍生物科技股份有限公司 | 一种脂肪酸酯纳米悬浮液、其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2651680B1 (fr) * | 1989-09-14 | 1991-12-27 | Medgenix Group Sa | Nouveau procede de preparation de microparticules lipidiques. |
| US5091187A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| KR100542816B1 (ko) * | 1996-08-22 | 2006-01-11 | 알티피 파마 코포레이션 | 수불용성 물질의 미립자를 포함하는 조성물 및 이것의 제조 방법 |
| IL162023A0 (en) * | 1998-03-30 | 2005-11-20 | Rtp Pharma Inc | Compositions containing microparticles of water-insoluble substances and method for their preparation |
| EP1079808B1 (en) * | 1998-05-29 | 2004-02-11 | Skyepharma Canada Inc. | Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
-
1999
- 1999-11-19 EP EP99960497A patent/EP1133280A1/en not_active Ceased
- 1999-11-19 WO PCT/US1999/027435 patent/WO2000030615A1/en not_active Application Discontinuation
- 1999-11-19 IL IL14319699A patent/IL143196A0/xx unknown
- 1999-11-19 AU AU17374/00A patent/AU767737B2/en not_active Ceased
- 1999-11-19 CA CA2349202A patent/CA2349202C/en not_active Expired - Fee Related
- 1999-11-19 JP JP2000583499A patent/JP5296954B2/ja not_active Expired - Fee Related
- 1999-11-19 KR KR1020017006123A patent/KR20010075713A/ko not_active Application Discontinuation
- 1999-11-19 CN CNB998156442A patent/CN1213733C/zh not_active Expired - Fee Related
-
2001
- 2001-05-17 IL IL143196A patent/IL143196A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL143196A (en) | 2012-01-31 |
| AU1737400A (en) | 2000-06-13 |
| JP5296954B2 (ja) | 2013-09-25 |
| WO2000030615A1 (en) | 2000-06-02 |
| CN1337877A (zh) | 2002-02-27 |
| CA2349202C (en) | 2012-06-19 |
| KR20010075713A (ko) | 2001-08-09 |
| AU767737B2 (en) | 2003-11-20 |
| CN1213733C (zh) | 2005-08-10 |
| JP2002530320A (ja) | 2002-09-17 |
| EP1133280A1 (en) | 2001-09-19 |
| CA2349202A1 (en) | 2000-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL147304A0 (en) | Interposer and method of making same | |
| GB2349493B (en) | Method of representing an object using shape | |
| PL342135A1 (en) | Method of obtaining absorbable microparticle | |
| SG74729A1 (en) | Method of forming bumps | |
| IL143196A0 (en) | Method of preparing stable suspensions of insoluble microparticles | |
| EP1242200A4 (en) | METHOD FOR PRODUCING "T" COUPLINGS | |
| IL149498A0 (en) | Suspension comprising oxcarbazepine | |
| PL341648A1 (en) | Novel method of obtaining kethymin | |
| GB9805417D0 (en) | Production of microparticles | |
| AU1291800A (en) | Microparticles and process for making microparticles | |
| PL341752A1 (en) | Method of obtaining aryloamino hydroxyantraquinones | |
| PL333401A1 (en) | Suspensions, method of obtaining them and their application | |
| GB9924752D0 (en) | Method of construction | |
| HK1045989A1 (zh) | 尿素製備方法 | |
| PL338405A1 (en) | Method of obtaining 2-quinoxalincarboxylic acid | |
| PL325802A1 (en) | Method of obtaining polyestroles | |
| HUP0103672A3 (en) | Process for preparation of exochelins | |
| PL333334A1 (en) | Method of obtaining silylethenes | |
| EG24104A (en) | Method of preparation of antidiphtheria | |
| PL320014A1 (en) | Method of obtaining tetramethylthiouramic disulphide | |
| PL336550A1 (en) | Method of decoposing 2-chloroethenylchloroarsazine | |
| GB9912169D0 (en) | Method of preparation of an antipersirant salt | |
| PL333032A1 (en) | Method of obtaining nalpha-benzyloxycarbonyl-l-lysine | |
| PL335392A1 (en) | Method of obtaining 4-hydroxy-beta-ionone | |
| PL335626A1 (en) | Method of obtaining 8beta-hydroxy-19-norandrostendione |